Published in Infect Immun on October 01, 1979
Immunosuppression of anti-sheep erythrocyte responses by glycerol teichoic acid immune complexes. Infect Immun (1980) 0.78
Precise standardization of reagents for complement fixation. Am J Trop Med Hyg (1963) 6.54
Lipoteichoic acids: a new class of bacterial antigen. Science (1975) 5.09
Immunological properties of teichoic acids. Bacteriol Rev (1973) 4.91
The occurrence of polyglycerophosphate as an antigenic component of various gram-positive bacterial species. J Exp Med (1959) 4.68
The teichoic acids. Adv Carbohydr Chem Biochem (1966) 2.95
Separation and properties of a red cell sensitizing substance from streptococci. J Bacteriol (1966) 2.83
Teichoic acid antibodies in staphylococcal and nonstaphylococcal endocarditis. Ann Intern Med (1972) 2.03
The teichoic acids. Adv Enzymol Relat Areas Mol Biol (1968) 1.89
Studies on the group F antigen of lactobacilli: antigenicity and serological specificity of teichoic acid preparations. J Gen Microbiol (1970) 1.84
Teichoic acids: antigenic determinants, chain separation, and their location in the cell wall. Proc Natl Acad Sci U S A (1966) 1.73
Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol (1973) 1.73
Nature of a red cell sensitizing substance from streptococci. J Bacteriol (1966) 1.58
The effect of a streptococcus pyogenes teichoic acid on the immune response of mice. J Immunol (1973) 1.56
Cyclical production of antibody as a regulatory mechanism in the immune response. Adv Immunol (1975) 1.50
Red cell-sensitizing antigen of group A streptococci. II. Immunological and immunopathological properties. Isr J Med Sci (1972) 1.49
Spontaneous adsorption of teichoic acid to erythrocytes. Immunochemistry (1973) 1.45
Effects of a streptococcal lipoteichoic acid on host responses in mice. Infect Immun (1976) 1.28
Naturally occurring cell-mediated immunity to purified glycerol-teichoic acid antigen in guinea pigs. J Immunol (1972) 1.23
Naturally-occurring antibodies to bacillary teichoic acids. J Immunol (1972) 1.11
Naturally occurring cellular and humoral immunity to teichoic acid in rats. Immunology (1974) 0.99
Polyagglutinable erythrocytes associated with bacteriogenic transfusion reactions. Vox Sang (1966) 0.91
Lipid-free glycerol teichoic acids with potent membrane-binding activity. Infect Immun (1978) 0.89
Environmental origin of natural antibodies to teichoic acid. Infect Immun (1977) 0.86
Modulation of the immune response to sheep erythrocytes by lipid-free glycerol teichoic acid. Infect Immun (1979) 0.85
Cyclic antibody formation to polyglycerophosphate in normal and injected rats. J Immunol (1977) 0.81
Animal companions and one-year survival of patients after discharge from a coronary care unit. Public Health Rep (1980) 4.07
Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer (2000) 1.97
Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography. Am J Cardiol (1984) 1.62
Management of malignant pineal germ cell tumors with residual mature teratoma. Neurosurgery (2001) 1.58
Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits. Circulation (1991) 1.57
Venous air embolism in sitting and supine patients undergoing vestibular schwannoma resection. Neurosurgery (1998) 1.48
Spontaneous adsorption of teichoic acid to erythrocytes. Immunochemistry (1973) 1.45
Heterogeneous enzyme immunoassay. J Histochem Cytochem (1979) 1.41
Social interaction and blood pressure. Influence of animal companions. J Nerv Ment Dis (1983) 1.40
Requirement for bone marrow-derived cells in resistance to Listeria. J Immunol (1974) 1.40
Ethical implications of renal transplants. JAMA (1967) 1.38
Cross-reactions of Streptococcus mutans due to cell wall teichoic acid. Infect Immun (1975) 1.24
Doctor-patient communications in a private family practice. J Fam Pract (1976) 1.24
Naturally occurring cell-mediated immunity to purified glycerol-teichoic acid antigen in guinea pigs. J Immunol (1972) 1.23
Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents. J Cardiovasc Pharmacol (1995) 1.17
Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res (1995) 1.12
Naturally-occurring antibodies to bacillary teichoic acids. J Immunol (1972) 1.11
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. J Med Chem (1999) 1.09
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. J Pharmacol Exp Ther (2000) 1.09
Acute bilateral anterior dislocation of the shoulders. Clin Orthop Relat Res (1979) 1.08
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position. J Med Chem (1998) 1.08
Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res (1973) 1.07
Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther (1997) 0.99
Naturally occurring cellular and humoral immunity to teichoic acid in rats. Immunology (1974) 0.99
Heterogenetic antigens of gram-positive bacteria. J Bacteriol (1966) 0.97
Endothelial barrier function. J Invest Dermatol (1989) 0.97
Evidence for messenger ribonucleic acid of an ammonium-inducible glutamate dehydrogenase and synthesis, covalent modification, and degradation of enzyme subunits in uninduced Chlorella sorokiniana cells. J Bacteriol (1981) 0.96
Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Thromb Haemost (1998) 0.96
Preparation and chemical composition of the cell walls of Streptococcus mutans. Infect Immun (1975) 0.96
Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp. J Med Chem (1994) 0.96
Survey of the seven serological types of Streptococcus mutans in six-year-old children. J Dent Res (1977) 0.95
A novel heart failure model induced by sequential coronary artery occlusions and tachycardiac stress in awake pigs. Am J Physiol (1999) 0.93
Polyagglutinable erythrocytes associated with bacteriogenic transfusion reactions. Vox Sang (1966) 0.91
Outcomes from adult implantation, the first 100 patients. J Laryngol Otol Suppl (1999) 0.91
Differential atrial versus ventricular activities of class III potassium channel blockers. J Pharmacol Exp Ther (1998) 0.89
Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system. J Pharmacol Exp Ther (2001) 0.89
Vitamin E enhances in vitro immune response by normal and nonadherent spleen cells. Proc Soc Exp Biol Med (1974) 0.89
A clinical study of tinnitus maskers. Br J Audiol (1985) 0.89
Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model. Am Heart J (1985) 0.89
Heart rate changes in the horse to human contact. Psychophysiology (1974) 0.89
Lipid-free glycerol teichoic acids with potent membrane-binding activity. Infect Immun (1978) 0.89
Human contact and cardiac arrhythmia in a coronary care unit. Psychosom Med (1977) 0.88
Effects of human contact on the heart activity of curarized patients in a shock-trauma unit. Am Heart J (1974) 0.87
Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death. J Cardiovasc Pharmacol (1991) 0.87
Social responding in dogs: heart rate changes to a person. Psychophysiology (1969) 0.87
The effects of human contact on cardiac arrhythmia in coronary care patients. J Nerv Ment Dis (1974) 0.87
The effect of petting on a classically conditioned emotional response. Behav Res Ther (1967) 0.87
In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel openers (-)-cromakalim, ZD6169 and WAY-133537 in rats. BJU Int (2003) 0.86
Characterization of antibodies specific for polyglycerophosphate. J Immunol (1974) 0.86
Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. J Cardiovasc Pharmacol (1985) 0.86
ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur J Pharmacol (2000) 0.86
Environmental origin of natural antibodies to teichoic acid. Infect Immun (1977) 0.86
The determination of quartz in airborne respirable granite dust by infrared spectrophotometry. Am Ind Hyg Assoc J (1973) 0.85
Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death. J Am Coll Cardiol (1987) 0.85
Modulation of the immune response to sheep erythrocytes by lipid-free glycerol teichoic acid. Infect Immun (1979) 0.85
Multicenter audiometric results with the Vibrant Soundbridge, a semi-implantable hearing device for sensorineural hearing impairment. Otolaryngol Clin North Am (2001) 0.84
Floor tile installation as a source of asbestos exposure. Am Rev Respir Dis (1971) 0.84
Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin. J Cardiovasc Pharmacol (1987) 0.84
The effects of talking on the blood pressure of hypertensive and normotensive individuals. Psychosom Med (1981) 0.84
Some aspects of sleep disturbance in coronary patients. Percept Mot Skills (1979) 0.84
HLA antigens in lichen sclerosus et atrophicus. Arch Dermatol (1990) 0.84
Trolox attenuates cortical neuronal injury induced by iron, ultraviolet light, glucose deprivation, or AMPA. Brain Res (1994) 0.83
Electrophysiologic actions and antifibrillatory efficacy of subacute left stellectomy in a conscious, post-infarction canine model of ischemic ventricular fibrillation. Int J Cardiol (1989) 0.83
Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position. J Med Chem (1997) 0.83
The effect of status on blood pressure during verbal communication. J Behav Med (1982) 0.83
The Birmingham bone anchored hearing aid programme: paediatric experience and results. J Laryngol Otol Suppl (1996) 0.82
Human speech and blood pressure. J Nerv Ment Dis (1980) 0.82
An experimentally pathogenic Bacillus species. I. Description and characterization of the organism. Can J Microbiol (1975) 0.82
Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templates. J Med Chem (1998) 0.81
Blood pressure changes while talking. Isr J Med Sci (1982) 0.81
Arrhythmogenic potential of positive inotropic agents. Basic Res Cardiol (2000) 0.81
Cyclic antibody formation to polyglycerophosphate in normal and injected rats. J Immunol (1977) 0.81
Cardiac electrophysiologic and antiarrhythmic actions of tedisamil. J Pharmacol Exp Ther (1995) 0.81
L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor. Bioorg Med Chem Lett (1998) 0.80
Denial in coronary care patients--an objective reassessment. Heart Lung (1983) 0.80
On the mechanisms of the feedback control of human brain wave activity. J Nerv Ment Dis (1971) 0.80
Electrode complications in 100 adults with multichannel cochlear implants. J Laryngol Otol Suppl (1999) 0.80
GH replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction. Am J Physiol (1996) 0.80
Facilitation of lethal ventricular arrhythmias by therapeutic digoxin in conscious post infarction dogs. Am Heart J (1986) 0.80
Preference of sheep for foods varying in flavors and nutrients. J Anim Sci (1996) 0.79
Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs. J Pharmacol Exp Ther (1985) 0.79
The XmnI restriction-modification system: cloning, expression, sequence organization and similarity between the R and M genes. Gene (1996) 0.79
Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499. J Cardiovasc Pharmacol (1994) 0.79
Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. Am Heart J (1985) 0.79
Effects of weaning, supplementation and gender on acquired immunity to Haemonchus contortus in lambs. Int J Parasitol (1995) 0.79
Automated blood pressure recording: the phenomenon of blood pressure elevations during speech. Angiology (1982) 0.79
A-315456: a selective alpha(1D)-adrenoceptor antagonist with minimal dopamine D(2) and 5-HT(1A) receptor affinity. Eur J Pharmacol (2001) 0.79
Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice. Pharmacol Biochem Behav (1999) 0.79
Antifibrillatory actions of bepridil and butyl-MDI, two intracellular calcium antagonists. Eur J Pharmacol (1985) 0.79
Practical aspects of the instrumental management of tinnitus. Br J Audiol (1985) 0.79